Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
Authors
Keywords
NPI, Breast density, Prognosis, Prediction, Nottingham prognostic index, HER2
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-02
DOI
10.1186/s12885-016-2892-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer, Version 3.2013
- (2017) Richard L. Theriault et al. Journal of the National Comprehensive Cancer Network
- The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome
- (2015) Amro Masarwah et al. BREAST CANCER RESEARCH AND TREATMENT
- Very low mammographic breast density predicts poorer outcome in patients with invasive breast cancer
- (2015) Amro Masarwah et al. EUROPEAN RADIOLOGY
- HER2 in Breast Cancer
- (2014) Uma Krishnamurti et al. ADVANCES IN ANATOMIC PATHOLOGY
- Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
- (2014) C. A. Drukker et al. BREAST CANCER RESEARCH AND TREATMENT
- Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer
- (2014) E A Rakha et al. BRITISH JOURNAL OF CANCER
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) E. Senkus et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic Tool
- (2013) Minkyu Jung et al. ANNALS OF SURGICAL ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients
- (2012) Nirmala Bhoo-Pathy et al. EUROPEAN JOURNAL OF CANCER
- Increased hyaluronan content and stromal cell CD44 associate withHER2positivity and poor prognosis in human breast cancer
- (2012) Päivi Auvinen et al. INTERNATIONAL JOURNAL OF CANCER
- Heterogeneity of breast cancer: etiology and clinical relevance
- (2011) Vanessa Almendro et al. Clinical & Translational Oncology
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer Diagnosis
- (2010) Vanya Van Belle et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom
- (2009) H E Campbell et al. BRITISH JOURNAL OF CANCER
- Prognostic Models: A Methodological Framework and Review of Models for Breast Cancer
- (2009) Douglas G. Altman CANCER INVESTIGATION
- Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
- (2009) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial
- (2008) M. Schmidt et al. ANNALS OF ONCOLOGY
- HER2 testing in the UK: further update to recommendations
- (2008) R A Walker et al. JOURNAL OF CLINICAL PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now